122 related articles for article (PubMed ID: 23440924)
1. Communicating quantitative risks and benefits in promotional prescription drug labeling or print advertising.
West SL; Squiers LB; McCormack L; Southwell BG; Brouwer ES; Ashok M; Lux L; Boudewyns V; O'Donoghue A; Sullivan HW
Pharmacoepidemiol Drug Saf; 2013 May; 22(5):447-58. PubMed ID: 23440924
[TBL] [Abstract][Full Text] [Related]
2. Health literacy knowledge among direct-to-consumer pharmaceutical advertising professionals.
Mackert M
Health Commun; 2011 Sep; 26(6):525-33. PubMed ID: 21469006
[TBL] [Abstract][Full Text] [Related]
3. Primary care physicians' use of FDA-approved prescription drug labels.
Sullivan HW; O'Donoghue AC; Aikin KJ
J Am Board Fam Med; 2014; 27(5):694-8. PubMed ID: 25201939
[TBL] [Abstract][Full Text] [Related]
4. But it's doctor recommended and I read the fine print: antecedents to drug companies' perceived credibility.
Park JS; Hoy MG
Health Mark Q; 2013; 30(1):63-79. PubMed ID: 23458482
[TBL] [Abstract][Full Text] [Related]
5. Prescription drug use in pregnancy: a retrospective, population-based study in British Columbia, Canada (2001-2006).
Daw JR; Mintzes B; Law MR; Hanley GE; Morgan SG
Clin Ther; 2012 Jan; 34(1):239-249.e2. PubMed ID: 22169049
[TBL] [Abstract][Full Text] [Related]
6. Benefit and risk information in prescription drug advertising: review of empirical studies and marketing implications.
Kopp SW; Bang HK
Health Mark Q; 2000; 17(3):39-56. PubMed ID: 11010219
[TBL] [Abstract][Full Text] [Related]
7. Consumers' preferences for the communication of risk information in drug advertising.
Davis JJ
Health Aff (Millwood); 2007; 26(3):863-70. PubMed ID: 17485767
[TBL] [Abstract][Full Text] [Related]
8. Fair balance in direct-to-consumer antidepressant print and television advertising, 1995-2007.
Avery RJ; Eisenberg M; Simon KI
J Health Commun; 2012; 17(3):250-77. PubMed ID: 22107455
[TBL] [Abstract][Full Text] [Related]
9. To inform or persuade? Direct-to-consumer advertising of prescription drugs.
Berndt ER
N Engl J Med; 2005 Jan; 352(4):325-8. PubMed ID: 15673797
[No Abstract] [Full Text] [Related]
10. Risk management frameworks for human health and environmental risks.
Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
[TBL] [Abstract][Full Text] [Related]
11. U.S. physician knowledge of the FDA-approved indications and evidence base for commonly prescribed drugs: results of a national survey.
Chen DT; Wynia MK; Moloney RM; Alexander GC
Pharmacoepidemiol Drug Saf; 2009 Nov; 18(11):1094-100. PubMed ID: 19697444
[TBL] [Abstract][Full Text] [Related]
12. Direct-to-consumer advertising of prescription drugs: balancing benefits and risks, and a way forward.
Kravitz RL; Bell RA
Clin Pharmacol Ther; 2007 Oct; 82(4):360-2. PubMed ID: 17851573
[No Abstract] [Full Text] [Related]
13. How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?
Allen D; Rixson L
Int J Evid Based Healthc; 2008 Mar; 6(1):78-110. PubMed ID: 21631815
[TBL] [Abstract][Full Text] [Related]
14. Direct-to-consumer advertising skepticism and the use and perceived usefulness of prescription drug information sources.
DeLorme DE; Huh J; Reid LN
Health Mark Q; 2009; 26(4):293-314. PubMed ID: 19916096
[TBL] [Abstract][Full Text] [Related]
15. An assessment of direct-to-consumer advertising of prescription drugs.
Calfee JE
Clin Pharmacol Ther; 2007 Oct; 82(4):357-60. PubMed ID: 17851572
[TBL] [Abstract][Full Text] [Related]
16. [Prescribing information for drugs--legal and regulatory implications].
Yahalom Z; Shani S
Harefuah; 2014 Nov; 153(11):671-4, 686. PubMed ID: 25563030
[TBL] [Abstract][Full Text] [Related]
17. Non-medical use and abuse of commonly prescribed medications.
Riggs P
Curr Med Res Opin; 2008 Mar; 24(3):869-77. PubMed ID: 18267053
[TBL] [Abstract][Full Text] [Related]
18. Direct-to-consumer advertising (DTCA) for prescription drugs: consumers' attitudes and preferences concerning its regulation in South Korea.
Suh HS; Lee D; Kim SY; Chee DH; Kang HY
Health Policy; 2011 Aug; 101(3):260-8. PubMed ID: 21705104
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Brief Summary Formats Through a Health Literacy Lens.
Sharp ML; Hall L; Eleftherion A; Simpson K; Neuhauser L
Ther Innov Regul Sci; 2019 Jan; 53(1):100-109. PubMed ID: 29714598
[TBL] [Abstract][Full Text] [Related]
20. Educating patients about their medications: the potential and limitations of written drug information.
Shrank WH; Avorn J
Health Aff (Millwood); 2007; 26(3):731-40. PubMed ID: 17485751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
